Exo Imaging

Exo Imaging has positioned itself as a disruptive force in the point-of-care ultrasound market by offering a fully integrated hardware and software platform centered on artificial intelligence. The company's FDA-cleared ecosystem includes the Iris handheld ultrasound device, SweepAI for guided scanning, Exo U for education, and Exo Works for workflow and billing, addressing key barriers to POCUS adoption like user variability and administrative burden. With strategic partnerships, a growing portfolio of AI-powered diagnostic insights, and demonstrated improvements in clinical workflow efficiency, Exo is targeting widespread adoption in hospitals, clinics, and medical education. The company remains private, leveraging venture funding to scale its commercial and technological footprint.

Integrated POCUS ecosystem combining a high-performance handheld ultrasound device (Iris) with on-device real-time AI for guided scanning (SweepAI), an AI-powered educational coach (Exo U), and a cloud-based workflow management platform (Exo Works).

Exo competes in the crowded point-of-care ultrasound market against large incumbents like Philips (Lumify), GE Healthcare (Vscan), and Butterfly Network, as well as AI software specialists. Its key differentiation is the fully integrated hardware-and-software platform with real-time, on-device AI guidance, which aims to reduce user variability and administrative burden more comprehensively than probe-only or basic app competitors.